Patents by Inventor Nicholas Ashton
Nicholas Ashton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938297Abstract: Methods and devices for eradicating biofilms and planktonic bacteria are provided. In on embodiment, a therapeutic delivery device comprised of at least a port and a antimicrobial releasing pouch and one or more therapeutic agents is provided to the mammal. In one aspect of at least one embodiment the releasing pouch has an internal reservoir comprised of a membrane that is configured to contain the one or more therapeutic agents that is to be administered to the mammal and the port is in fluid communication with the pouch and configured such that the pouch can be refilled with one or more therapeutic agents via the port. In other aspect of at least one embodiment the method is able to fully eradicate 109 colony forming units (CFU) of methicillin-resistant Staphylococcus aureus (MRSA) within a 24 hr period.Type: GrantFiled: August 15, 2020Date of Patent: March 26, 2024Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Dustin Williams, Nicholas Ashton
-
Patent number: 11931538Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: GrantFiled: August 15, 2020Date of Patent: March 19, 2024Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Dustin Williams, Nicholas Ashton
-
Patent number: 11911583Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: GrantFiled: August 15, 2020Date of Patent: February 27, 2024Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Dustin Williams, Nicholas Ashton
-
Patent number: 11911584Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: GrantFiled: August 15, 2020Date of Patent: February 27, 2024Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Dustin Williams, Nicholas Ashton
-
Patent number: 11853807Abstract: Generally described, one or more aspects of the present application relate to scaling a cluster of compute capacity used to execute containerized applications or tasks. For example, a waiting area can be maintained, in which tasks that are requested to be executed in a cluster but are not able to be accommodated in the cluster due to the cluster not having sufficient compute capacity usable to execute such tasks are stored. The scaling of the cluster can be performed based on the characteristics of the tasks in the waiting area, such that the cost associated with adding too much compute capacity to the cluster can be reduced, while also reducing the time it takes to reach the desired level of compute capacity that can accommodate all of the requested tasks.Type: GrantFiled: December 1, 2020Date of Patent: December 26, 2023Assignee: Amazon Technologies, Inc.Inventors: Nicholas Ashton Coult, David Michael Westbrook, Anoop Kapoor
-
Patent number: 11679245Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: GrantFiled: August 15, 2020Date of Patent: June 20, 2023Assignee: UNIVERSITY OF UTAH RESEARCH FOUNDATIONInventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20230149687Abstract: A device for delivering one or more therapeutic agents to a mammal is provided. In at least one embodiment, the device includes (1) a port for receiving one or more therapeutic agents that is to be delivered to a mammal subcutaneously, the port having a stem; (2) a reservoir that is comprised of at least a compliant elastic material and a rate-controlling membrane that allows the one or more therapeutic agents to be delivered to the mammal at a controlled rate and the rate-controlling membrane and the compliant elastic material being attached to each other and the reservoir being capable of being inflated to contain one or more therapeutic agents and deflated, the reservoir being in fluid communication with the stem of the device.Type: ApplicationFiled: January 18, 2023Publication date: May 18, 2023Inventors: Dustin Williams, Nicholas Ashton, Christophe Courimault, Brian Barnum, Andrew J Moore
-
Publication number: 20210031016Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: ApplicationFiled: August 15, 2020Publication date: February 4, 2021Inventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20210031017Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: ApplicationFiled: August 15, 2020Publication date: February 4, 2021Inventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20210031018Abstract: Methods and devices for eradicating biofilms and planktonic bacteria are provided. In on embodiment, a therapeutic delivery device comprised of at least a port and a antimicrobial releasing pouch and one or more therapeutic agents is provided to the mammal. In one aspect of at least one embodiment the releasing pouch has an internal reservoir comprised of a membrane that is configured to contain the one or more therapeutic agents that is to be administered to the mammal and the port is in fluid communication with the pouch and configured such that the pouch can be refilled with one or more therapeutic agents via the port. In other aspect of at least one embodiment the method is able to fully eradicate 109 colony forming units (CFU) of methicillin-resistant Staphylococcus aureus (MRSA) within a 24 hr period.Type: ApplicationFiled: August 15, 2020Publication date: February 4, 2021Inventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20200376251Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: ApplicationFiled: August 15, 2020Publication date: December 3, 2020Inventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20200376250Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: ApplicationFiled: August 15, 2020Publication date: December 3, 2020Inventors: Dustin Williams, Nicholas Ashton
-
Patent number: 10744313Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: GrantFiled: July 27, 2018Date of Patent: August 18, 2020Assignee: University of Utah Research FoundationInventors: Dustin Williams, Nicholas Ashton
-
Publication number: 20190227813Abstract: A networked computer system is described herein. The networked computer system includes a mobile computing device and a mobile application server in communication with the mobile computing device. The mobile application server computer includes a processor programmed to display a company culture selection webpage on the mobile computing device including one or more user selectable company culture indicators. The mobile application server then receives a user selection of a company culture indicator and displays an activity capture screen that allows the user to operate a camera of the mobile computing device to capture a digital photo image of an event, select an employee ID associated with one or more employees included in the photo image, and input a textual description of the captured activity.Type: ApplicationFiled: July 31, 2018Publication date: July 25, 2019Inventor: Nicholas Ashton Daniels
-
Publication number: 20190030311Abstract: A therapeutic delivery device that provides a controlled release of high doses of a therapeutic agent in a local area, sustains the high dose controlled release with a percutaneous port for refilling the device, and is versatile for use with multiple types of therapeutic agents and/or implant systems. A rate determining/controlled release membrane is used to decrease the molecular mobility of the therapeutic compounds thereby controlling the therapeutic release profile. The therapeutic delivery device includes a body defining an internal reservoir for receiving a therapeutic agent and including a first membrane for providing a controlled release of the therapeutic agent to the surgical site, a port in fluid communication with the reservoir, a sleeve configured to encapsulate the body, and a rigid housing configured to support the body and a portion of the sleeve, the rigid housing configured to release the body and the sleeve after the body and the sleeve are anchored position relative to the surgical site.Type: ApplicationFiled: July 27, 2018Publication date: January 31, 2019Inventors: Dustin Williams, Nicholas Ashton
-
Patent number: 9883252Abstract: A method implementable on a computing device for generating interstitial material for video content includes generating at least one instantiated script by inserting metadata related to the video content into at least one script template, scoring the instantiated scripts according to a predefined set of weights associated with a profile for a viewing audience to produce scored scripts, and selecting from said scored scripts according to at least said scoring for rendering as said interstitial material. Related apparatus and methods are also described.Type: GrantFiled: July 9, 2013Date of Patent: January 30, 2018Assignee: Cisco Technology, Inc.Inventors: Nicholas Ashton Hall, Stephen Tallamy, Avraham Poupko
-
Publication number: 20150334458Abstract: A method and system for audience segmentation is described, the method and system including preparing a plurality of guidebooks of prior probability distributions for content items and user profile attributes, the prior probabilities and user profile attributes being extractable from within audience measurement data, receiving raw audience measurement data, analyzing, at a processor, the received raw audience measurement data using the prepared plurality of guidebooks, generating a plurality of clusters of data per user household as a result of the analyzing, correlating viewing activity to each cluster within an identified household, predicting a profile of a viewer corresponding to each cluster within the identified household, applying classifier rules in order to assign viewing preference tags to each predicted profile, and assigning each predicted profile viewing preferences based on the viewing preference tags assigned to that profile Related systems, methods, and apparatus are also described.Type: ApplicationFiled: July 1, 2014Publication date: November 19, 2015Inventors: Prabhakar Srinivasan, Trevor Smith, Nicholas Ashton Hall, Trevor Whinmill
-
Publication number: 20150143413Abstract: A method implementable on a computing device for generating interstitial material for video content includes generating at least one instantiated script by inserting metadata related to the video content into at least one script template, scoring the instantiated scripts according to a predefined set of weights associated with a profile for a viewing audience to produce scored scripts, and selecting from said scored scripts according to at least said scoring for rendering as said interstitial material. Related apparatus and methods are also described.Type: ApplicationFiled: July 9, 2013Publication date: May 21, 2015Inventors: Nicholas Ashton Hall, Stephen Tallamy, Avraham Poupko
-
Patent number: 8370892Abstract: An interactive method includes receiving background video including a multiplicity of video frames, at least one of the multiplicity of video frames include a plurality of sub-pictures, each of the plurality of sub-pictures representing an alternative background (1200), and switching between a first sub-picture of the plurality of sub-pictures and a second sub-picture of the plurality of sub-pictures (1210).Type: GrantFiled: May 17, 2010Date of Patent: February 5, 2013Assignee: NDS LimitedInventors: Ian R. Shelton, Michael B Costello, Ronnie Israel Dan, Nicholas Thexton, Nicholas Ashton Hall, James Geoffrey Walker, Stuart P Ashby, Neil Cormican, Rahul Chakkara
-
Publication number: 20120023543Abstract: A system for displaying electronic program guide information about a plurality of video items on a screen, the system including a display module to display a plurality of pages layering into the screen, each of the pages including a plurality of graphical panels associated with the video items, and a user input module to receive a user input to turn at least one of the pages such that the at least one page is peeled away from other ones of the pages in order to bring the graphical panels of the at least one page in or out of view, wherein the display module is operative to show the turning of the at least one page bringing the at least one page in or out of view. Related apparatus and methods are also described.Type: ApplicationFiled: September 27, 2011Publication date: January 26, 2012Applicant: NDS LimitedInventors: Ian Shelton, James Geoffrey Walker, Kevin Murray, Michael Costello, Neil Cormican, Anita Chandra, Nicholas Ashton Hall